CaƱeda, Renz M.
HRN: 25-67-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
09/24/2024
09/30/2024
IV
8.5mg
OD
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes